What can BPC-157 be used to treat in dogs
There may be mild side effects, such as nausea, but these are typically temporary and manageable with proper medical guidance
This is a predictable consequence of slowed gastric emptying, one of the mechanisms through which cagrilintide reduces food intake
In the situation of proper use of the peptide, none of them should appear, especially since BPC-157 has excellent bioavailability
Cell Metab 15: 110121 Bott AJ, Peng IC, Fan Y, Faubert B, Zhao L, Li J, Neidler S, Sun Y, Jaber N, Krokowski D et al (2015) Oncogenic MYC induces expression of glutamine synthetase through promoter demethylation
Treating insulin resistance in type 2 diabetes with metformin and thiazolidinediones